Creation of a long-acting rilpivirine prodrug nanoformulation

JR Hilaire, AN Bade, B Sillman, N Gautam… - Journal of Controlled …, 2019 - Elsevier
Antiretroviral therapy requires lifelong daily dosing to attain viral suppression, restore
immune function, and improve quality of life. As a treatment alternative, long-acting (LA) …
被引用次数：32 相关文章
[HTML] nih.gov

[HTML][HTML] Creation of a Long-Acting Rilpivirine Prodrug Nanoformulation

JR Hilaire, AN Bade, B Sillman, N Gautam… - Journal of controlled …, 2019 - ncbi.nlm.nih.gov
Antiretroviral therapy requires lifelong daily dosing to attain viral suppression, restore
immune function, and improve quality of life. As a treatment alternative, long-acting (LA) …

Creation of a long-acting rilpivirine prodrug nanoformulation

JR Hilaire, AN Bade, B Sillman… - Journal of …, 2019 - experts.nebraska.edu
Antiretroviral therapy requires lifelong daily dosing to attain viral suppression, restore
immune function, and improve quality of life. As a treatment alternative, long-acting (LA) …

Creation of a long-acting rilpivirine prodrug nanoformulation

JR Hilaire, AN Bade, B Sillman… - … : official journal of …, 2019 - pubmed.ncbi.nlm.nih.gov
Antiretroviral therapy requires lifelong daily dosing to attain viral suppression, restore
immune function, and improve quality of life. As a treatment alternative, long-acting (LA) …

Creation of a long-acting rilpivirine prodrug nanoformulation

JR Hilaire, S Sravanam, HS Fox, Y Alnouti… - Journal of Controlled …, 2019 - hero.epa.gov
Antiretroviral therapy requires lifelong daily dosing to attain viral suppression, restore
immune function, and improve quality of life. As a treatment alternative, long-acting (LA) …

Creation of a long-acting rilpivirine prodrug nanoformulation.

JR Hilaire, AN Bade, B Sillman, N Gautam… - Journal of Controlled …, 2019 - europepmc.org
Antiretroviral therapy requires lifelong daily dosing to attain viral suppression, restore
immune function, and improve quality of life. As a treatment alternative, long-acting (LA) …

Creation of a long-acting rilpivirine prodrug nanoformulation.

JR Hilaire, AN Bade, B Sillman, N Gautam… - Journal of Controlled …, 2019 - europepmc.org
Antiretroviral therapy requires lifelong daily dosing to attain viral suppression, restore
immune function, and improve quality of life. As a treatment alternative, long-acting (LA) …

[引用][C] Creation of a long-acting rilpivirine prodrug nanoformulation

JR Hilaire, AN Bade, B Sillman, N Gautam, J Herskovitz… - 2019